Craniofacial deformities (CFDs) develop following oncological resection, trauma, or
congenital disorders. Trauma is one of the top five causes of death globally, with rates …

Background Ameloblastoma (AM), the benign counterpart of ameloblastic carcinoma, is a
benign odontogenic tumor of epithelial origin, naturally aggressive, with unlimited growth …

Ameloblastoma is a rare, benign, but locally aggressive odontogenic tumor that originates
from the epithelial cells involved in tooth development. The surgical approach to treating an …

We studied 21 patients who underwent radical ameloblastoma excision followed by
immediate reconstruction. Comorbidities, consumption of alcohol and/or tobacco and BMI …

Ameloblastoma (AM) is the most common, locally aggressive odontogenic tumor. It
comprises about 1% of all head and neck neoplasms. It occurs mainly in young adults in …

Background Ameloblastoma may present a significant treatment challenge in the locally
advanced, recurrent and metastatic setting. Comprehensive genomic profiling (CGP) can …

Background Craniopharyngiomas and ameloblastomas are tumors of epithelial origin,
mostly characterized by a benign course, slow growth and for being locally invasive. Some …

Ameloblastoma is a rare benign epithelial odontogenic neoplasm, but with great clinical
implications, as despite its benignity and slow growth, most cases are locally aggressive …

Unicystic ameloblastoma (UA) differs from conventional ameloblastoma by presenting in the
younger population with a lower recurrence rate and has a unilocular appearance on …

Aim: The aim of the study is to assess the expression of Glut1 in dentigerous cysts,
odontogenic keratocysts, and ameloblastoma. Settings and Design: The study was …